Showing results (21-30 of 180) with videos related to
Sort By:
Pageof 18
Journal of Clinical Psychopharmacology|August 1, 1997
Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind studyE Mundo, L Bianchi, L BellodiInternational Clinical Psychopharmacology|April 12, 2000
Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorderE Mundo, G Maina, C UslenghiPharmacopsychiatry|January 14, 2015
May non-antipsychotic drugs improve cognition of schizophrenia patients?M Buoli, A C AltamuraPsychopharmacologia|December 31, 1975
Plasma renin activity in depressed patients treated with increasing doses of lithium carbonateA C Altamura, A MorgantiInternational Journal of Psychiatry in Clinical Practice|June 13, 2014
Quetiapine in acute mania: a case report (with a six-month follow-up)C Altamura Donato Madaro Daniele SalvadoriPsychiatry Research|October 1, 1989
Dexamethasone suppression test in positive and negative schizophreniaC Altamura, G Guercetti, M PercudaniInternational Journal of Psychiatry in Clinical Practice|June 19, 2014
Fluoxetine augmentation in bipolar disorder patients on maintenance lithium treatmentL Tondo, P Mannu, F Silvetti, et al.Antimicrobial Agents and Chemotherapy|April 4, 1998
A novel peptide-grafted liposomal delivery system targeted to macrophagesG Banerjee, S Medda, M K BasuThe Journal of Antimicrobial Chemotherapy|December 11, 1999
Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal formsS Medda, S Mukhopadhyay, M K BasuJournal of Cellular Biochemistry|April 1, 1997
Developmental regulation of osteocalcin expression in MC3T3-E1 osteoblasts: minimal role of the proximal E-box cis-acting promoter elementsL D Quarles, S R Siddhanti, S MeddaPageof 18